CBE-001-SEOS
Fully, Coated, Removable, Self-expanding Oesophageal Stents for the Prevention of Oesophageal Stricture Following Endoscopic Mucosal Resection of Short Segment Barrett's With High Grade Dysplasia and Early Cancer.
Sponsor study identifier
interventional
12
1 country
1
Study Start
January 2012
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2013
Actual (reported)Study Completion
January 2014
Actual (reported)The purpose of this study is to investigate whether preventative placement of a removable oesophageal stent reduces the rate of scar tissue, or stricture formation after removing the precancerous or early cancerous Barrett's mucosa by Endoscopic Mucosal Resection (EMR). The stent will be placed 10-14 days after initial EMR. The stent will then be removed 8 weeks later by repeat Endoscopy. Patients will be followed up weekly following insertion of the oesophageal stent.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2014
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2012
Date type not reportedThis date has not been verified as actual or estimated.
March 11, 2012
Actual (reported)March 14, 2012
Actual (reported)January 2013
Actual (reported)January 2014
Actual (reported)Improvement in Stricture Formation
Initial evaluation of Dysphagia score which is used to assess the stricture formation prior to EMR. Followed by weekly phone calls to assess ability to swallow liquids and food.
12 weeks
Patients enrolled will receive a fully coated, removable, self-expanding oesophageal stent.
Insertion of the fully coated, removable, self-expanding oesophageal stent for the prevention of oesophageal strictures.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Holt BA, Jayasekeran V, Williams SJ, Lee EY, Bahin FF, Sonson R, Lord RV, Bourke MJ. Early metal stent insertion fails to prevent stricturing after single-stage complete Barrett's excision for high-grade dysplasia and early cancer. Gastrointest Endosc. 2015 Apr;81(4):857-64. doi: 10.1016/j.gie.2014.08.022. Epub 2014 Oct 16.
Michael Bourke, MBBS
WSLHD
12 participants (actual enrollment reported by the registry).
First Submitted
March 11, 2012
First Posted
March 14, 2012
Study Start
January 2012
Date type not reportedThis date has not been verified as actual or estimated.
RCT of the Cutting Balloon Versus a High Pressure Balloon for the Treatment of Arteriovenous Fistula Stenoses
Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
Contact the study team to confirm eligibility.
Primary Completion
January 2013
Actual (reported)Study Completion
January 2014
Actual (reported)Last Updated
March 23, 2021
Record last verified: 2021-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: